Provectus Pharmaceuticals
Knoxville
About Provectus Pharmaceuticals
Provectus Pharmaceuticals focuses on creating sophisticated medicines to target and eliminate the most lethal cancers. Provectus also creates ground-breaking biotechnologies to improve vaccine production and detect viruses. It develops and markets innovative over-the-counter skin care products, as well as licensing unique technologies for therapeutic and cosmetic medical devices.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $10.6M
- Funding stage: IPO
- Last round: Post-IPO Equity (Apr 2014)
- Ticker: otcqb:PVCT
- Website: pvct.com
- Phone: 866-594-5999
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/provectus-pharmaceuticals-1297182 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.